Report Detail

Other Global Gene Editing Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • RnM3939949
  • |
  • 26 March, 2020
  • |
  • Global
  • |
  • 110 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Table of Contents

    1 Gene Editing Technology Market Overview

    • 1.1 Product Overview and Scope of Gene Editing Technology
    • 1.2 Classification of Gene Editing Technology by Type
      • 1.2.1 Global Gene Editing Technology Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Gene Editing Technology Revenue Market Share by Type in 2019
      • 1.2.3 Homologous Recombination
      • 1.2.4 Meganuclease
    • 1.3 Global Gene Editing Technology Market by Application
      • 1.3.1 Overview: Global Gene Editing Technology Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Agriculture
      • 1.3.3 Medical
      • 1.3.4 Other
    • 1.4 Global Gene Editing Technology Market by Regions
      • 1.4.1 Global Gene Editing Technology Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Gene Editing Technology (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Gene Editing Technology Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Editing Technology Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Editing Technology Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Gene Editing Technology Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Editing Technology Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Thermo Fisher Scientific
      • 2.1.1 Thermo Fisher Scientific Details
      • 2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Thermo Fisher Scientific SWOT Analysis
      • 2.1.4 Thermo Fisher Scientific Product and Services
      • 2.1.5 Thermo Fisher Scientific Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Allele Biotech
      • 2.2.1 Allele Biotech Details
      • 2.2.2 Allele Biotech Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Allele Biotech SWOT Analysis
      • 2.2.4 Allele Biotech Product and Services
      • 2.2.5 Allele Biotech Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Cellectics
      • 2.3.1 Cellectics Details
      • 2.3.2 Cellectics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Cellectics SWOT Analysis
      • 2.3.4 Cellectics Product and Services
      • 2.3.5 Cellectics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 SIGMA ALDRICH
      • 2.4.1 SIGMA ALDRICH Details
      • 2.4.2 SIGMA ALDRICH Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 SIGMA ALDRICH SWOT Analysis
      • 2.4.4 SIGMA ALDRICH Product and Services
      • 2.4.5 SIGMA ALDRICH Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Bio Rad
      • 2.5.1 Bio Rad Details
      • 2.5.2 Bio Rad Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Bio Rad SWOT Analysis
      • 2.5.4 Bio Rad Product and Services
      • 2.5.5 Bio Rad Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Dharmacon
      • 2.6.1 Dharmacon Details
      • 2.6.2 Dharmacon Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Dharmacon SWOT Analysis
      • 2.6.4 Dharmacon Product and Services
      • 2.6.5 Dharmacon Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Lonza
      • 2.7.1 Lonza Details
      • 2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Lonza SWOT Analysis
      • 2.7.4 Lonza Product and Services
      • 2.7.5 Lonza Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 AstraZeneca
      • 2.8.1 AstraZeneca Details
      • 2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 AstraZeneca SWOT Analysis
      • 2.8.4 AstraZeneca Product and Services
      • 2.8.5 AstraZeneca Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 CRISPR Therapeutics
      • 2.9.1 CRISPR Therapeutics Details
      • 2.9.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 CRISPR Therapeutics SWOT Analysis
      • 2.9.4 CRISPR Therapeutics Product and Services
      • 2.9.5 CRISPR Therapeutics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Recombinetics
      • 2.10.1 Recombinetics Details
      • 2.10.2 Recombinetics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Recombinetics SWOT Analysis
      • 2.10.4 Recombinetics Product and Services
      • 2.10.5 Recombinetics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 GE Healthcare
      • 2.11.1 GE Healthcare Details
      • 2.11.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 GE Healthcare SWOT Analysis
      • 2.11.4 GE Healthcare Product and Services
      • 2.11.5 GE Healthcare Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 QIAGEN NV
      • 2.12.1 QIAGEN NV Details
      • 2.12.2 QIAGEN NV Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 QIAGEN NV SWOT Analysis
      • 2.12.4 QIAGEN NV Product and Services
      • 2.12.5 QIAGEN NV Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Editas Medicine
      • 2.13.1 Editas Medicine Details
      • 2.13.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Editas Medicine SWOT Analysis
      • 2.13.4 Editas Medicine Product and Services
      • 2.13.5 Editas Medicine Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Agilent Technologies
      • 2.14.1 Agilent Technologies Details
      • 2.14.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Agilent Technologies SWOT Analysis
      • 2.14.4 Agilent Technologies Product and Services
      • 2.14.5 Agilent Technologies Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Gene Editing Technology Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Gene Editing Technology Players Market Share
      • 3.2.2 Top 10 Gene Editing Technology Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Gene Editing Technology Revenue and Market Share by Regions
    • 4.2 North America Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 4.5 South America Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Gene Editing Technology Revenue and Growth Rate (2015-2020)

    5 North America Gene Editing Technology Revenue by Countries

    • 5.1 North America Gene Editing Technology Revenue by Countries (2015-2020)
    • 5.2 USA Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Gene Editing Technology Revenue and Growth Rate (2015-2020)

    6 Europe Gene Editing Technology Revenue by Countries

    • 6.1 Europe Gene Editing Technology Revenue by Countries (2015-2020)
    • 6.2 Germany Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 6.3 UK Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 6.4 France Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Gene Editing Technology Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Gene Editing Technology Revenue by Countries

    • 7.1 Asia-Pacific Gene Editing Technology Revenue by Countries (2015-2020)
    • 7.2 China Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 7.5 India Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Gene Editing Technology Revenue and Growth Rate (2015-2020)

    8 South America Gene Editing Technology Revenue by Countries

    • 8.1 South America Gene Editing Technology Revenue by Countries (2015-2020)
    • 8.2 Brazil Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Gene Editing Technology Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Gene Editing Technology by Countries

    • 9.1 Middle East & Africa Gene Editing Technology Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Gene Editing Technology Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Gene Editing Technology Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Gene Editing Technology Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Gene Editing Technology Market Forecast by Type (2019-2024)
    • 10.3 Homologous Recombination Revenue Growth Rate (2015-2025)
    • 10.4 Meganuclease Revenue Growth Rate (2015-2025)

    11 Global Gene Editing Technology Market Segment by Application

    • 11.1 Global Gene Editing Technology Revenue Market Share by Application (2015-2020)
    • 11.2 Gene Editing Technology Market Forecast by Application (2019-2024)
    • 11.3 Agriculture Revenue Growth (2015-2020)
    • 11.4 Medical Revenue Growth (2015-2020)
    • 11.5 Other Revenue Growth (2015-2020)

    12 Global Gene Editing Technology Market Size Forecast (2021-2025)

    • 12.1 Global Gene Editing Technology Market Size Forecast (2021-2025)
    • 12.2 Global Gene Editing Technology Market Forecast by Regions (2021-2025)
    • 12.3 North America Gene Editing Technology Revenue Market Forecast (2021-2025)
    • 12.4 Europe Gene Editing Technology Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Gene Editing Technology Revenue Market Forecast (2021-2025)
    • 12.6 South America Gene Editing Technology Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Gene Editing Technology Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Gene Editing Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.


      The Gene Editing Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.


      Market segmentation
      Gene Editing Technology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.


      By Type, Gene Editing Technology market has been segmented into:
      Homologous Recombination
      Meganuclease


      By Application, Gene Editing Technology has been segmented into:
      Agriculture
      Medical
      Other


      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Editing Technology market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Editing Technology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Editing Technology market.


      The report offers in-depth assessment of the growth and other aspects of the Gene Editing Technology market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


      Competitive Landscape and Gene Editing Technology Market Share Analysis
      Gene Editing Technology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Editing Technology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Editing Technology sales, revenue and market share for each player covered in this report.


      The major players covered in Gene Editing Technology are:
      Thermo Fisher Scientific
      Allele Biotech
      Cellectics
      SIGMA ALDRICH
      Bio Rad
      Dharmacon
      Lonza
      AstraZeneca
      CRISPR Therapeutics
      Recombinetics
      GE Healthcare
      QIAGEN NV
      Editas Medicine
      Agilent Technologies


      Summary:
      Get latest Market Research Reports on Gene Editing Technology. Industry analysis & Market Report on Gene Editing Technology is a syndicated market report, published as Global Gene Editing Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Gene Editing Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,848.53
      5,697.06
      3,239.32
      6,478.64
      379,358.00
      758,716.00
      266,746.20
      533,492.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report